This paper seeks to contribute to understanding of existing policies related to harm reduction in Cambodia, as well as the challenges to and opportunities for improvement in order to reduce the health and socio-economic harms associated with drug use.
This Paper provides an analysis of critical public health problems for the Philippine prison population, in relation to HIV/AIDS and hepatitis C (HCV), and offers recommendations
for addressing these ‘twin epidemics.’
IDPC and MUCD provide an overview of the key models of regulation and offer general recommendations to improve public policies in areas where legislation is already in place and to improve decision-making in countries where reform is pending.
This paper provides recommendations for overcoming challenges in light of current policies and practices in Thailand so that the drug treatment system can result in improved health and human rights outcomes for people who use drugs and people dependant on drugs.
IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.
This IDPC progress report provides an overview of our activities between 2016 and 2017, including our continuing efforts to build capacity for drug policy advocacy and the numerous publications and resources produced during this period.
In an effort to help digest and contextualise the UNGASS Outcome Document, this IDPC briefing paper explores a selection of key themes by analysing the consensus-based language agreed by UN member states during high-level meetings over the last quarter of a century.
IDPC, WOLA, CIM and Dejusticia have published a series to share examples of innovative approaches that incorporate a gender perspective and the principles of public health and human rights into drug policy.